Itraconazole-amphotericin B antagonism in Aspergillus fumigatus: An E-test-based strategy

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 10, 2000, Pages 2915-2918

  Kontoyiannis, D P ^a   Lewis, R E ^a   Sagar, N ^a   May, G ^a   Prince, R A ^a   Rolston, K V I ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ITRACONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CULTURE MEDIUM; FUNGUS CULTURE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; DRUG INTERACTIONS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; SUPPORT, NON-U.S. GOV'T;

EID: 0033797867     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.10.2915-2918.2000     Document Type: Article

References (14)

1. Antifungal resistance trends towards the year 2000. Implications for therapy and new approaches
2. Therapeutic outcome in invasive aspergillosis
3. In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents
4. Problems of antifungal in vitro testing in Aspergillus fumigatus
5. Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi
6. Clinical pharmacology of systemic antifungal agents: A comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development
7. Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: A randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B
8. Assessment of antifungal activities of fluconazole and amphotericin B administered alone and in combination against Candida albicans by using a dynamic in vitro mycotic infection model
9. Combination systemic antifungal therapy for cryptococcosis, candidiasis, and aspergillosis
10. Effects of antifungal agent combinations administered simultaneously and sequentially against Aspergillus fumigatus
11. Inhibition of sterol biosynthesis in Candida albicans by imidazole-containing antifungals
12. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi: Proposed standard
13. Use of amphotericin B with azole antifungal drugs: What are we doing?
14. Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients